Manuscripts
Showing 1530 manuscripts.
Results of the flow cytometry ACTG quality control program: analysis and findings
Citation
Helene M.A. Paxton, Pamela Gill Kidd, Alan Landay, Janis V. Giorgi, Neal Flomenberg, Edwin B. Walker, Fred T. Valentine, John L. Fahey, Rebecca S. Gelman. Results of the flow cytometry ACTG quality control program: analysis and findings. Clinical Immunology and Immunopathology (Now Clin Immunol). 1989. 52: 68-84.Year
1989
Journal
Clinical Immunology and Immunopathology (Now Clin Immunol)
Recovery of human immunodeficiency virus type 1 from supernatant fluid of routine viral cultures
Citation
E. Sia, Janet Ailene Englund, Kim Sannerud, Karen Hansen, Nila Shah, Henry H. Balfour. Recovery of human immunodeficiency virus type 1 from supernatant fluid of routine viral cultures. Journal of Clinical Microbiology. 1989. 27: 1664-6.Year
1989
Journal
Journal of Clinical Microbiology
Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus
Citation
Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. Morbidity and Mortality Weekly Report. 1989. 38: 1-9.Year
1989
Journal
Morbidity and Mortality Weekly Report
Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone
Citation
Stephen A. Spector, D. Ripley, Karen Hsia. Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone. Antimicrobial Agents and Chemotherapy. 1989. 33: 920-3.Year
1989
Journal
Antimicrobial Agents and Chemotherapy
Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine
Citation
Mark A. Jacobson, Donald I. Abrams, Paul Volberding, P. Bacchetti, Judith C. Wilber, Richard E. Chaisson, S. M. Crowe, W. Howard, A. Moss. Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine. Journal of Infectious Diseases. 1989. 159: 1029-36.Year
1989
Journal
Journal of Infectious Diseases
Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs
Citation
Richard A. Koup, John L. Sullivan, Peter H. Levine, Doreen Barbara Brettler, Anna Mahr, Gail Mazzara, Sara J. McKenzie, Dennis Panicali. Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. Blood. 1989. 73: 1909-14.Year
1989
Journal
Blood
Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: expression and replication in macrophages
Citation
David J. Eilbott, Nancy Peress, Harold Burger, Debra La Neve, Jan Orenstein, Howard E. Gendelman, Roberta Seidman, Barbara Weiser. Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: expression and replication in macrophages. Proceedings of the National Academy of Sciences of the United States of America. 1989. 86: 3337-41.Year
1989
Journal
Proceedings of the National Academy of Sciences of the United States of America
Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome
Citation
Mark A. Jacobson, James O'Donnell, John Mills. Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Antimicrobial Agents and Chemotherapy. 1989. 33: 736-41.Year
1989
Journal
Antimicrobial Agents and Chemotherapy
Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis
Citation
Francesca Aweeka, John G. Gambertoglio, John Mills, Mark A. Jacobson. Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis. Antimicrobial Agents and Chemotherapy. 1989. 33: 742-5.Year
1989
Journal
Antimicrobial Agents and Chemotherapy
The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker
Citation
Stephen A. Spector, C. Kennedy, J. Allen McCutchan, Sam Bozzette, R. G. Straube, James D. Connor, Douglas D. Richman. The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker. Journal of Infectious Diseases. 1989. 159: 822-8.Year
1989
Journal
Journal of Infectious Diseases